Role of Ewing sarcoma proteins EWS/FLI1 and EWS in mitosis

Prof. Mizuki Azuma, Department of Molecular Biosciences
University of Kansas

Project dates: 2012-2015

Mentor: Berl Oakley

Dr. Azuma proposes to elucidate the molecular mechanism whereby the Ewing sarcoma fusion protein EWS/FLI1 leads to chromosome instability and malignant transformation. Ewing sarcoma is the second most common form of bone cancer in children and adolescents. EWS/FLI1 is a chimeric fusion protein containing EWS-derived sequences at the amino-terminal region fused to the carboxy-terminal regions of the ETS transcription factor FLI1. FLI1 is essential for hemangioblast differentiation, whereas the in vivo function of EWS is not well understood.

Dr. Azuma and her colleagues previously reported that both expression of the EWS/FLI1 fusion protein and knockdown of endogenous EWS in zebrafish embryos and in HeLa cells leads to mitotic defects.  They subsequently demonstrated that EWS/FLI1 interacts with wildtype EWS, and this interaction lead to inhibition of EWS activity.  Their research goal is to elucidate whether and how mitotic defects in EWS/FLI1 expressing and endogenous EWS knockdown cells lead to chromosome instability and potentially to Ewing sarcoma formation.  They will address these questions by establishing and analyzing an Ewing sarcoma model in zebrafish.


Recent News

May 2017
CMADP Research Project Investigator co-recipient of NCI R33 grant

April 2017
CMADP Graduate, one of ACS's 'Must See Presenters', speaks on latest "chemobrain" findings at Spring 2017 ACS National Meeting

February 2017
CMADP Project Investigators co-author Top Downloaded article in Lab on a Chip

CMADP Graduate's research featured on cover of Genetics and in other journals

View all news »

Upcoming Events

TBA

KU Today